Recent advances in immunology and biology have opened new horizons in cancer therapy, included in the expanding array of cancer treatment options, which are immunotherapies, or cancer vaccines, for both solid and blood borne cancers. Cancer Vaccines: Challenges and Opportunities in Translation is the first text in the field to bring immunotherapy treatments from the laboratory trial to the bedside for the practicing oncologist.
Cancer Vaccines: Challenges and Opportunities in Translation:
Critically analyzes the most promising classes of investigational immunotherapies, integrating their scientific rationale and clinical potential
Discusses "theranostics" as pertaining to immunotherapy, i.e., using molecular diagnostics to identify patients that would most likely benefit from a therapy
Presents the new paradigm of biomarker guided R&D and clinical development in immunotherapy of cancer
Reviews bottlenecks in translational process of immunotherapies and offers strategies to resolve them
Cancer Vaccines: Challenges and Opportunities in Translation:
Critically analyzes the most promising classes of investigational immunotherapies, integrating their scientific rationale and clinical potential
Discusses "theranostics" as pertaining to immunotherapy, i.e., using molecular diagnostics to identify patients that would most likely benefit from a therapy
Presents the new paradigm of biomarker guided R&D and clinical development in immunotherapy of cancer
Reviews bottlenecks in translational process of immunotherapies and offers strategies to resolve them
Share This Book: